Jag Capital Management LLC Sells 9,704 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jag Capital Management LLC reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 22.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 32,798 shares of the medical equipment provider’s stock after selling 9,704 shares during the quarter. Intuitive Surgical accounts for 2.4% of Jag Capital Management LLC’s portfolio, making the stock its 13th biggest holding. Jag Capital Management LLC’s holdings in Intuitive Surgical were worth $17,119,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter valued at about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in Intuitive Surgical in the fourth quarter valued at about $31,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter valued at about $33,000. Finally, Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the fourth quarter valued at about $36,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $566.98 on Tuesday. The firm has a market capitalization of $201.95 billion, a price-to-earnings ratio of 88.45, a PEG ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The business has a 50 day simple moving average of $570.66 and a 200-day simple moving average of $530.08.

Analyst Ratings Changes

A number of brokerages have commented on ISRG. Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. UBS Group upped their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Finally, Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now directly owns 473 shares of the company’s stock, valued at $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,598 shares of company stock valued at $7,223,467 in the last ninety days. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.